Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on December 11, 2013, covering events that occurred on December 10, 2013. The filing addresses corporate governance changes, specifically the election of a new director and amendments to the company's bylaws regarding director retirement age.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed relates to director compensation: Dr. Thomas J. Lynch, Jr. will receive an annual retainer of $90,000, a committee retainer of $15,000, and deferred share units valued at $160,000 on the date of grant.
Material Changes
- Board Election: The Board of Directors elected Thomas J. Lynch, Jr., M.D., to serve as a director effective January 1, 2014. Dr. Lynch is the director of the Yale Cancer Center and physician-in-chief of the Smilow Cancer Hospital at Yale-New Haven.
- Board Size: The size of the Board of Directors was increased to eleven members.
- Committee Assignment: Dr. Lynch will serve on the Science and Technology Committee.
- Bylaw Amendment: The Board amended Bylaw 17(d) to raise the mandatory retirement age for non-employee directors, the CEO, and retired CEOs from 72 to 75. The change is effective December 10, 2013.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. No material risks or contingencies were disclosed in this report. The filing notes that Dr. Lynch is independent under NYSE Listing Standards and that there are no related party transactions between the Company and Dr. Lynch.
Investor Verification Checklist
- Verify the effective date of Dr. Lynch's board membership (January 1, 2014).
- Confirm the new mandatory retirement age for directors (75 years old) as per the amended bylaws.
- Review the attached press release (Exhibit 99.1) for additional context on the board election.
- Check the revised Bylaws (Exhibit 3.1) for the full text of the amendment to Bylaw 17(d).